Skip to main content
Premium Trial:

Request an Annual Quote

Michael Callaghan, Mark Smedley, Victor Ambros

Premium
Michael Callaghan has resigned from Vermillion’s board of directors, the company stated in a filing with the US Securities and Exchange Commission last week.
 
Callaghan was a member of the company’s audit and compensation committees. The company said he resigned for personal reasons and not as the result of any disagreement.
 

 
Invitrogen announced that it has named Mark Smedley, the firm’s global head of operations, to lead the integration team for its $6.7 billion acquisition of Applied Biosystems.
 

 
RXi Pharmaceuticals has appointed University of Massachusetts scientist Victor Ambros to its scientific advisory board. Ambros is best known for his work in discovering microRNA. He was a professor at Dartmouth College from 1992 to 2007, and before that he studied genetic pathways as a post-doctoral fellow at the Massachusetts Institute of Technology.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.